Oct 28 PR
Sai Life Sciences receives EIRs from USFDA for India R&D & Manufacturing facilities
October 28, 2024 05:51 ET | SAI LIFE SCIENCES LIMITED
HYDERABAD, India, Oct. 28, 2024 (GLOBE NEWSWIRE) -- Sai Life Sciences, the fastest-growing Indian Contract Research, Development and Manufacturing Organization (CRDMO)[1], announced that it has...
PharmAla Biotech Logo 800 x 422.png
PharmAla Comments on USFDA Decision regarding MDMA-Assisted Therapy and Announces Patent Granting for ALA-002
August 09, 2024 18:18 ET | PharmAla Biotech
PharmAla expresses disappointment in USFDA's decision to request a third Phase 3 for MDMA and announces the patent granting for a safer MDMA analog variant
PharmAla Biotech Logo 800 x 422.png
PharmAla Submits Pre-IND Dossier for Novel MDMA Analog to FDA
November 02, 2022 09:00 ET | PharmAla Biotech
VANCOUVER, British Columbia, Nov. 02, 2022 (GLOBE NEWSWIRE) -- PharmAla Biotech (CSE:MDMA) is pleased to announce that it has submitted its pre-IND data meeting package to the US Food and Drug...
Jubilant Pharma.jpg
Jubilant Radiopharma Receives Approval from Health Canada for Drax Exametazime®
January 27, 2020 16:05 ET | Jubilant Pharma
YARDLEY, Pa., Jan. 27, 2020 (GLOBE NEWSWIRE) -- Jubilant Radiopharma, the Radiopharmaceutical Division of Jubilant Pharma Ltd, announced today that the company received approval from Health Canada...
lexingtonbiologo.jpg
Lexington Announces Non-Brokered Private Placement
August 27, 2018 09:00 ET | Lexington Biosciences, Inc.
NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES AND DOES NOT CONSTITUTE AN OFFER OF THE SECURITIES DESCRIBED HEREIN VANCOUVER, British Columbia, Aug. 27,...